Copy
European Stroke Organisation
 

ESOC 2022 Newsletter Vol. 2

Dear Colleagues and Friends,


The first conference day is already over, and we shared some fantastic insights into brand-new research results, and important clinical trials.

In this newsletter, we provide you with today’s press release focused on the plenary session as well as scientific session reports.

Stay tuned for Day 2 of ESOC 2022!
 

News from ESOC 2022

ESOC 2022 Plenary Highlights: Wednesday 4 May

  • Alteplase compared to Tenecteplase (ACT) Randomized Controlled Trial
 
  • Tenecteplase versus Alteplase for Management of Acute Ischemic Stroke (NOR-TEST 2 Part A): A Phase 3, Randomised, Open, Label, Blinded Endpoint Trial
 
  • The Paramedic Norwegian Acute Stroke Prehospital Project (PARANASPP): Diagnostics and Triage of Acute Stroke by
    Paramedics Using the National Institutes of Health Stroke Scale (NIHSS)
 
  • The Melbourne Mobile Stroke Unit Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in The Ambulance (TASTE-A)
 
  • Secondary Prevention by Structured Semi-Interactive Stroke Prevention Package in India (SPRINT INDIA): A Randomized
    Controlled Trial
 
  • Apixaban for Treatment of Embolic Stroke of Undetermined Source - ATTICUS Randomised Trial
 
  • Early vs standard tracheostomy in ventilated patients with severe
    stroke: results of the randomized, multicenter, international trial
    (SETPOINT2)
 
  • Procedural Sedation Versus General Anaesthesia in Anterior
    Circulation Large Vessel Occlusion Thrombectomy: The Anaesthesia management in Endovascular Therapy for Ischemic Stroke (AMETIS) Randomized Controlled Trial
 
  • Endovascular Treatment for Acute Basilar Artery Occlusion - A Multi-centre Randomised Controlled Trial (ATTENTION)
Press Release

Session Report: Acute Stroke care delivery: difficulties but also improvements imposed by the COVID-19 era

The session looked at how stroke care was impacted by the COVID-19 over the past years and what has changed for the better [more...]


Session Report: ESMINT - ESO Joint Symposium: Peristent frontiers facing acute reperfusion therapies

This joint symposium provided excellent and challenging lectures as well as a colorful discussion. Read the full summary. [more...]


Session Report: Leveling up stroke care in Europe - Removing inequality

Presenters in this session explored inequality in stroke care in a variety of populations and countries. [more...]

Photo Gallery

Facebook
Twitter
LinkedIn
Website
YouTube
Email
Copyright © 2022 European Stroke Organisation (ESO), All rights reserved.

Our mailing address is:
European Stroke Organisation (ESO) · Reinacherstrasse 131 · Basel 4053 · Switzerland

Unsubscribe from this list